HDAC inhibitors: magic bullets, dirty drugs or just another targeted therapy

Cancer Lett. 2009 Aug 8;280(2):123-4. doi: 10.1016/j.canlet.2009.02.038. Epub 2009 Mar 19.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Epigenesis, Genetic*
  • Histone Deacetylase Inhibitors
  • Histone Deacetylases / metabolism*
  • Humans
  • Hydroxamic Acids / adverse effects
  • Hydroxamic Acids / pharmacology*
  • Hydroxamic Acids / therapeutic use
  • Neoplasms / drug therapy
  • Vorinostat

Substances

  • Antineoplastic Agents
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Vorinostat
  • Histone Deacetylases